Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Archer Capital Management Return, AUM, and Holdings

Archer Capital Management is a hedge fund advisory firm based in New York City and Beverly Hills, California. It was founded in January 2006 by Eric Edidin and Joshua Lobel. Eric Edidin received a BA  with highest distinction Degree from the University of Michigan and an MBA from Harward Business School. His professional experience includes being Senior Vice President at York Capital, where he became well known in the sector of investments; prior to that, he has worked as an Associate at Blackstone Group in the private investment bank’s restructuring team, and also as an Associate in Global Investments at Morgan Stanley Capital Partners and as Vice President and Founding Team Member at Etrana. As per Joshua Lobel, before co-founding Archer Capital Management, he was Principal at Redwood Capital Management. Joshua Lobel graduated from the University of California and holds an MBA from the University of Pennsylvania.

Their fund pursues a middle-market distressed and special situations debt and equity securities investment strategy. It launches and manages hedge funds for their clients by investing in diversified financial instruments and securities, including syndicated bank debt, high yield bonds, non-performing distressed fixed income securities, equities and convertible securities. Other investments include mortgage notes, leases, trade claims and other equity credit instruments. Currently, the firm serves as the investment manager to three private funds. Archer Capital Management’s investment philosophy must be very bright as it has brought back some good returns in recent years.

Eric Edidin - Archer Capital

For example, its Archer Capital Fund achieved its best net return in 2013 with a brilliant 13.27% in the sector of fixed income asset back loans. Then in 2014, it generated a return of 5.44%, followed by a down year – 2015, in which it lost 7.43%. In 2016 Archer Capital Fund stood back on its feet with a return of 4.36%. 2017 was also a good year for the fund, as it has returned 10.62%. From January through October 2018 it gained 2.51%. Archer Capital Fund’s total return stood at 101.00%, for a compound annual return of 5.7%, while its worst drawdown was 14.18. According to its Plain Brochure, as of February 2017, Archer Capital Management holds $1.08 billion in regulatory assets on a discretionary basis and no regulatory assets on a non-discretionary basis.

At the end of the third quarter 2018, Archer Capital Management’s equity portfolio was valued at $135.12 million. The biggest stake it held was in Everi Holdings Inc (NYSE:EVRI), with the fund reporting 1.87 million shares, worth $17.15 million. The fund actually lowered its stake in the company during the third quarter 16%, but it still remained its largest holding occupying 12.69% of its portfolio. More about similar changes and the fund’s third quarter investment moves you can find on the next page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.